Screening of ferritin light polypeptide 460-461InsA mutation in Parkinson's disease patients in North America

被引:5
作者
Chen, R [1 ]
Langston, JW [1 ]
Chan, P [1 ]
机构
[1] Parkinsons Inst, Sunnyvale, CA 94089 USA
关键词
ferritin light polypeptide; Parkinson's disease; mutation screening; iron metabolism;
D O I
10.1016/S0304-3940(02)01185-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
An insertional (460-461lnsA) mutation in the ferritin light polypeptide (FTL) gene was recently reported in some patients with a familial form of basal ganglia degeneration with varying extrapyramidal manifestations. Some of the affected family members presented with a phenotype indistinguishable from typical Parkinson's disease (PD). In this study, 253 patients with a clinical diagnosis of idiopathic PD were screened for the insertion in the FTL gene by polymerase chain reaction-restriction fragment length polymorphism method. The results showed that none of them had the mutation, indicating that genetic defects in the FTL gene are unlikely to be a common cause of typical PD, at least in a North America population. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:144 / 146
页数:3
相关论文
共 20 条
  • [1] Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease
    Curtis, ARJ
    Fey, C
    Morris, CM
    Bindoff, LA
    Ince, PG
    Chinnery, PF
    Coulthard, A
    Jackson, MJ
    Jackson, AP
    McHale, DP
    Hay, D
    Barker, WA
    Markham, AF
    Bates, D
    Curtis, A
    Burn, J
    [J]. NATURE GENETICS, 2001, 28 (04) : 350 - 354
  • [2] DEXTER DT, 1987, LANCET, V2, P1219
  • [3] ALTERATIONS IN LEVELS OF IRON, FERRITIN, AND OTHER TRACE-METALS IN NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA
    DEXTER, DT
    JENNER, P
    SCHAPIRA, AHV
    MARSDEN, CD
    [J]. ANNALS OF NEUROLOGY, 1992, 32 : S94 - S100
  • [4] DECREASED FERRITIN LEVELS IN BRAIN IN PARKINSONS-DISEASE
    DEXTER, DT
    CARAYON, A
    VIDAILHET, M
    RUBERG, M
    AGID, F
    AGID, Y
    LEES, AJ
    WELLS, FR
    JENNER, P
    MARSDEN, CD
    [J]. JOURNAL OF NEUROCHEMISTRY, 1990, 55 (01) : 16 - 20
  • [5] INDEXES OF OXIDATIVE STRESS AND MITOCHONDRIAL-FUNCTION IN INDIVIDUALS WITH INCIDENTAL LEWY BODY DISEASE
    DEXTER, DT
    SIAN, J
    ROSE, S
    HINDMARSH, JG
    MANN, VM
    COOPER, JM
    WELLS, FR
    DANIEL, SE
    LEES, AJ
    SCHAPIRA, AHV
    JENNER, P
    MARSEN, CD
    [J]. ANNALS OF NEUROLOGY, 1994, 35 (01) : 38 - 44
  • [6] Double K L, 1999, Adv Neurol, V80, P287
  • [7] Double KL, 2000, ADV RES NEURODEGENER, V8, P37
  • [8] ALTERED BRAIN METABOLISM OF IRON AS A CAUSE OF NEURODEGENERATIVE DISEASES
    GERLACH, M
    BENSHACHAR, D
    RIEDERER, P
    YOUDIM, MBH
    [J]. JOURNAL OF NEUROCHEMISTRY, 1994, 63 (03) : 793 - 807
  • [9] Occupational exposures to metals as risk factors for Parkinson's disease
    Gorell, JM
    Johnson, CC
    Rybicki, BA
    Peterson, EL
    Kortsha, GX
    Brown, GG
    Richardson, RJ
    [J]. NEUROLOGY, 1997, 48 (03) : 650 - 658
  • [10] Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence
    Graham, JM
    Paley, MNJ
    Grünewald, RA
    Hoggard, N
    Griffiths, PD
    [J]. BRAIN, 2000, 123 : 2423 - 2431